Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Broadly SARS-CoV-2 neutralizing monoclonal antibodies and uses thereof

Broadly SARS-CoV-2 neutralizing monoclonal antibodies and uses thereof

US Patent 12281155 · Granted Apr 22, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Broadly neutralizing antibodies that target HIV ENV V3 N-glycans2025
Broadly-neutralizing anti-HIV antibodies2023
Broadly-neutralizing anti-HIV antibodies2021
Broadly neutralizing antibody directed against HIV-1 GP1402019
Broadly-neutralizing anti-HIV antibodies2018